• 1. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 2. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
• 3. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 4. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 5. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzenesulfonyl compounds Benzenesulfonyl halides

Professional Introduction to 4-Bromo-2-methylbenzene-1-sulfonyl chloride (CAS No. 139937-37-4)

4-Bromo-2-methylbenzene-1-sulfonyl chloride, with the chemical formula C?H?BrClO?S, is a highly versatile sulfonating agent widely utilized in pharmaceutical and agrochemical research. This compound belongs to the class of aryl sulfonates and serves as a crucial intermediate in the synthesis of various biologically active molecules. Its unique structural features, including a bromine substituent at the para position relative to the sulfonyl chloride group and a methyl group at the ortho position, make it an attractive building block for medicinal chemists seeking to develop novel therapeutic agents.

The CAS No. 139937-37-4 identifier is essential for ensuring the correct compound is referenced in scientific literature, regulatory filings, and industrial applications. This numbering system provides a standardized way to distinguish 4-Bromo-2-methylbenzene-1-sulfonyl chloride from other structurally similar compounds, facilitating accurate procurement and handling in research and production environments.

In recent years, 4-Bromo-2-methylbenzene-1-sulfonyl chloride has garnered significant attention due to its role in synthesizing sulfonamide derivatives. Sulfonamides are a cornerstone of modern pharmacology, with numerous drugs on the market exhibiting potent antimicrobial, anti-inflammatory, and anticancer properties. The sulfonyl chloride moiety in this compound allows for facile introduction of sulfonamide groups into target molecules through nucleophilic substitution reactions, making it an indispensable reagent in drug discovery pipelines.

One of the most compelling applications of 4-Bromo-2-methylbenzene-1-sulfonyl chloride lies in its use as a precursor for designing kinase inhibitors. Kinases are enzymes central to many cellular signaling pathways and are frequently implicated in diseases such as cancer and diabetes. By modifying the aromatic core of this compound, researchers can fine-tune its binding affinity to specific kinase targets. For instance, recent studies have demonstrated that derivatives of 4-Bromo-2-methylbenzene-1-sulfonyl chloride exhibit inhibitory activity against tyrosine kinases, which are critical therapeutic targets in oncology.

The bromine atom at the para position provides an additional handle for further functionalization via cross-coupling reactions such as Suzuki-Miyaura or Buchwald-Hartwig couplings. These transformations enable the introduction of diverse substituents at specific positions on the aromatic ring, expanding the structural diversity of potential drug candidates. Moreover, the methyl group at the ortho position influences electronic and steric properties, allowing for fine-tuning of metabolic stability and pharmacokinetic profiles.

Advances in computational chemistry have further highlighted the utility of 4-Bromo-2-methylbenzene-1-sulfonyl chloride in rational drug design. Molecular modeling studies indicate that subtle modifications to its structure can significantly enhance binding interactions with biological targets. For example, computational screening has identified that certain derivatives exhibit improved solubility and reduced toxicity compared to parent compounds, aligning with current trends toward developing more patient-friendly therapeutics.

In agrochemical research, 4-Bromo-2-methylbenzene-1-sulfonyl chloride has been employed in synthesizing novel herbicides and fungicides. The sulfonamide scaffold is known to disrupt essential metabolic pathways in plants and fungi, offering a mechanism-based approach to crop protection. Researchers have leveraged its reactivity to develop compounds that exhibit broad-spectrum activity while maintaining environmental safety profiles.

The synthesis of 4-Bromo-2-methylbenzene-1-sulfonyl chloride typically involves bromination followed by sulfonylation of 2-methylphenol (o-cresol). While traditional methods rely on harsh conditions or hazardous reagents, recent innovations have focused on greener alternatives. For instance, catalytic bromination techniques using transition metal complexes have reduced waste generation without compromising yield or purity. Similarly, solvent-free sulfonylation reactions have minimized environmental impact while maintaining reaction efficiency.

The growing demand for high-purity intermediates has driven advancements in purification technologies for 4-Bromo-2-methylbenzene-1-sulfonyl chloride. Chromatographic methods such as flash chromatography or preparative HPLC are commonly employed to isolate desired products from reaction mixtures. Additionally, spectroscopic techniques like NMR and mass spectrometry play critical roles in confirming structural integrity before downstream applications.

Regulatory considerations also play a significant role in handling 4-Bromo-2-methylbenzene-1-sulfonyl chloride. Compliance with Good Manufacturing Practices (GMP) ensures that pharmaceutical-grade material meets stringent quality standards. Documentation of synthesis routes, impurity profiles, and stability data is essential for regulatory submissions worldwide.

Future directions for research involving 4-Bromo-2-methylbenzene-1-sulfonyl chloride may explore its role in developing next-generation therapeutics targeting emerging diseases or resistant pathogens. The adaptability of its molecular framework makes it a promising candidate for generating libraries of diverse compounds through combinatorial chemistry approaches.

In conclusion,4-Bromo-2-methylbenzene-1-sulfonyl chloride (CAS No. 139937-37-4) remains a cornerstone intermediate in synthetic chemistry with far-reaching implications across multiple industries. Its unique structural attributes enable diverse functionalization strategies while serving as a platform for discovering novel biologically active molecules.

• 69321-56-8(5-Bromo-2-methylbenzene-1-sulfonyl chloride)
• 175278-24-7(4-bromo-2-ethylbenzene-1-sulfonyl chloride)
• 26763-71-3(Benzenesulfonylchloride, methyl-)
• 885520-33-2(3-Bromo-5-methylbenzene-1-sulfonyl chloride)
• 351003-50-4(4-bromo-2,6-dimethyl-benzenesulfonyl chloride)
• 886501-61-7(3-bromo-2-methylbenzene-1-sulfonylchloride)
• 89794-06-9(2-Bromo-4-methylbenzenesulfonyl chloride)
• 773-64-8(Mesitylenesulfonyl chloride)
• 609-60-9(2,4-dimethylbenzene-1-sulfonyl chloride)
• 2905-29-5(2,6-Dimethylbenzene-1-sulfonyl chloride)